GLP-1 Drugs Move Into Brain Disorders as Trials Begin
Early clinical results are pushing GLP-1-like drugs into alcohol use disorder and Parkinson’s disease, but the brain mechanism remains unclear.
From stroke to neurodegeneration — the science and its clinical impact.
From stroke to neurodegeneration — the science and its clinical impact.